Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects

Clinical trial NCT05657613 · COMPLETED

Trial details

NCT number: NCT05657613
Sponsor: CTI BioPharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Interactions

Start date: 2023-01-03
Primary completion: 2023-06-08
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.